FAB — Fusion Antibodies Share News
0.000.00%
Last trade - 00:00- £7.57m
- £6.86m
- £2.11m
Fusion Antibodies - Contract win
Fusion Antibodies - AGM statement H1 trading and research update
RCS - Fusion Antibodies - Launch of new customer-focused website
Fusion Antibodies - Posting of Annual Report & Notice of AGM
Fusion Antibodies - REPLACEMENT: Final Results
Fusion Antibodies - Grant of Canadian Patent for OptiMAL
Fusion Antibodies - Notice of Results
Fusion Antibodies - Notice of acceptance of patent in Australia
Fusion Antibodies - Grant of options
Fusion Antibodies - Holding(s) in Company
Fusion Antibodies - Holding(s) in Company
Brief: Fusion Antibodies Says Co Remains Cautiously Optimistic For FY2027
Fusion Antibodies - Year-end trading statement
Brief: Fusion Antibodies Agrees To Transfer Certain Background IP To Finn Therapeutics
Fusion Antibodies - Antibody IP transfer agreement
Fusion Antibodies - Director/PDMR Shareholding
Fusion Antibodies - Holding(s) in Company
Fusion Antibodies - Holding(s) in Company
Fusion Antibodies - Issue of Director Shares